Skip to content

FERLOE

Active Private limited companyfounded 2022active for 4 yearsEgenhovenstraat 40, 3060 BertemKBO/BCE: BE 0782.256.597

Lifetime

4 annual accounts with figures on one time axis
peak €242,849 (2025)
€242,849▲ 14.1%
peak €187,590 (2025)
€187,590▲ 14.9%
peak €336,006 (2024)
€100▼ 100.0%
€245,199▲ 358%
Board1 name since 2022
1 director
Documentsfilings and deeds
02-04-2026120 days before the deadline
2025micro format
Gross margin from €212,795 to €242,849Dividend €523,496Equity from €336,006 to €100Debts from €53,514 to €245,199Cash from €73,599 to €172,935

Key points

from the 2025 annual accounts

Equity

€100 from €336,006 in 2024

Equity fell by 100% in 1 year.

Turnover

≈ €450,000 estimated

The micro format states no turnover.

Debts

€245,199 100% of the balance sheet
Suppliers 0%Taxes and wages 20%Other 80%

Of this, €244,443 falls due within a year.

Liquidity

1.00 was 7.30 in 2024

Short-term debts rose from €53,314 to €244,443.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 34 to 120 days before the end of the period.

Position in the sector

0.0%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,156 companies had the same profile as FERLOE has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,156 companies, not a prediction for FERLOE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 18-02-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0782256597
Registered office moved from Herent to Bertem New registered office: Egenhovenstraat 40 te 3060 Bertem · Previous registered office: Weibeemd 17 te 3020 Herent · General meeting of 16-12-2022 · Gazette deed
Incorporation Founding capital of €100, 100 shares · Founder: · Appointment: (director) · published on 18-02-2022 · Gazette deed
First establishment At the time the registered office was still in Herent, Weibeemd 17.
All 11 events

Comparable companies

same main activity, similar in size and age
Company
FERLOE Bertem €245,299 €242,849 0.0% -
Dr. Neirynck Orthopedie Lubbeek €250,074 €248,677 1.0% -
DR. DE ROP JONAS Opwijk €217,049 €238,436 11.1% -
AMANI Herent €282,135 €228,131 4.2% -
EMILIE CLAEYS Scherpenheuvel-Zichem €220,193 €227,719 24.2% -
DR. ELINE VAN HOVE Bertem €231,000 €212,556 41.6% -
Dr. E. Fiévez Keerbergen €225,856 €275,219 0.4% -

These companies have the same main activity as FERLOE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €217,000 and €282,000, founded between 2021 and 2022.

Official details

Source: KBO
Status
Active since 16-02-2022Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.328.056.1213060 Bertem, registered on 16-02-2022
Financial year end
31 December
Peppol
Reachable since 04-11-2025
Company details

Annual accounts 2025

€245,299▼ 37.0%
Filing
Filed on 02-04-2026, 120 days before the end of the filing period
Financials

Insights on FERLOE

FERLOE files the micro format. That format states no turnover. The gross margin rose from €67,427 in 2022 to €242,849 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FERLOE

What is the company number of FERLOE?
The company number of FERLOE is 0782.256.597. The VAT number is the same number with BE in front: BE 0782.256.597.
Where is FERLOE based?
The registered office is at Egenhovenstraat 40, 3060 Bertem.Company details
What does FERLOE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of FERLOE?
FERLOE is a private limited company (BV).
When was FERLOE founded?
FERLOE was founded on 16-02-2022.
Is FERLOE still active?
Yes, FERLOE is an active enterprise in the KBO register.
What is the turnover of FERLOE?
The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €242,849 and 40 comparable companies (NACE 86220). It probably lies between €380,000 and €600,000.Financials
Is FERLOE profitable?
In financial year 2025, FERLOE made a profit of €187,590.
Where can I find the annual accounts of FERLOE?
FERLOE filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FERLOE due?
FERLOE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.